Use este identificador para citar ou linkar para este item: http://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2032
Registro completo de metadados
Campo DCValorIdioma
dc.contributor.authorKawano-Dourado, Leticiaen_US
dc.contributor.authorDoyle, Tracy J.en_US
dc.contributor.authorBonfiglioli, Karinaen_US
dc.contributor.authorSawamura, Márcio V. Y.en_US
dc.contributor.authorNakagawa, Renato H.en_US
dc.contributor.authorArimura, Fábio E.en_US
dc.contributor.authorLee, Hye J.en_US
dc.contributor.authorBueno, Cleoniceen_US
dc.contributor.authorCarvalho, Carlos R. R.en_US
dc.contributor.authorSabbag, Maria Lauraen_US
dc.contributor.authorMolina, Camilaen_US
dc.contributor.authorRosas, Ivan O.en_US
dc.contributor.authorKairalla, Ronaldo A.en_US
dc.date.accessioned2024-09-16T13:54:54Z-
dc.date.available2024-09-16T13:54:54Z-
dc.date.issued2020-
dc.identifier.citationKawano-Dourado, Leticia, et al. “Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis”. Chest, vol. 158, no 4, outubro de 2020, p. 1546–54. DOI.org (Crossref), https://doi.org/10.1016/j.chest.2020.04.061.en_US
dc.identifier.issn0090-3132-
dc.identifier.urihttp://repo.saocamilo-sp.br:8080/jspui/handle/123456789/2032-
dc.description.abstractBACKGROUND: Interstitial lung abnormalities (ILA) and interstitial lung disease (ILD) are seen in up to 60% of individuals with rheumatoid arthritis (RA), some of which will progress to have a significant impact on morbidity and mortality rates. Better characterization of progressive interstitial changes and identification of risk factors that are associated with pro gression may enable earlier intervention and improved outcomes. RESEARCH QUESTION: What are baseline characteristics associated with RA-ILD progression? STUDY DESIGN AND METHODS: We performed a retrospective study in which all clinically indicated CT chest scans in adult individuals with RA from 2014 to 2016 were evaluated for interstitial changes, and the data were further subdivided into ILA and ILD based on clinical record review. Progression was determined visually and subsequently semiquantified. RESULTS: Those individuals with a spectrum of interstitial changes (64 of 293) were older male smokers and less likely to be receiving biologics/small molecule disease-modifying antirheumatic drugs. Of 44% of the individuals with ILA, 46% had had chest CT scans performed for nonpulmonary indications. Of the 56 individuals with ILA/ILD with sequential CT scans, 38% had evidence of radiologic progression over 4.4 years; 29% of of individuals with ILA progressed. Risk factors for progressive ILA/ILD included a subpleural distribution and higher baseline involvement. INTERPRETATION: Of 293 individuals with RA with clinically indicated CT scans, interstitial changes were observed in 22%, one-half of whom had had a respiratory complaint at the time of imaging; radiologic progression was seen in 38%. Of individuals with progressive ILA, one-half had had baseline CT scans performed for nonpulmonary indications. Subpleural distribution and higher baseline ILA/ILD extent were risk factors associated with progression. Prospective longitudinal studies of RA-ILA are necessary.-
dc.publisherNational Library of Medicineen_US
dc.relation.ispartofChest, v. 158, n. 4, 2020en_US
dc.subjectDoenças pulmonares intersticiaisen_US
dc.subjectFibrose pulmonaren_US
dc.subjectRadiologiaen_US
dc.subjectArtrite reumatoideen_US
dc.titleBaseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritisen_US
dc.typeArtigo de Periódicoen_US
dc.identifier.doi10.1016/j.chest.2020.04.061-
Aparece nas coleções:Artigos de Periódicos

Arquivos associados a este item:
Não existem arquivos associados a este item.


Os itens no repositório estão protegidos por copyright, com todos os direitos reservados, salvo quando é indicado o contrário.